Prostate drug shows ‘exciting’ promise for slowing Parkinson’s disease

A drug used to treat enlarged prostates could slow down Parkinson’s disease progression and improve movement symptoms, according to new research. The study published in the Journal of Clinical Investigation suggests that the prostate drug, terazosin, can slow the loss of brain cells in various models of Parkinson’s, including in mice. This also led to increased dopamine levels.  The reason for this protection was thought to be because the drug may provide brain cells with more energy by boosting an enzyme called PGK1. In addition to studying the potential of terazosin in the lab, the researchers also looked at existing data from